AI assistant
INSMED Inc — Director's Dealing 2013
May 28, 2013
30150_dirs_2013-05-28_9b044705-945b-499b-85d1-e7a2f4404b94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED INC (INSM)
CIK: 0001104506
Period of Report: 2013-05-23
Reporting Person: Drechsler Andrew T (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-23 | Stock Option-Right to Buy | $12.44 | A | 30000 | Acquired | 2023-05-23 | Common Stock (30000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option-Right to Buy | $6.65 | 2022-11-07 | Common Stock (175000) | 175000 | Direct |
| Stock Option-Right to Buy | $6.90 | 2023-03-20 | Common Stock (50000) | 50000 | Direct |
Footnotes
F1: These options shall become exercisable with respect to 25% of the shares of common stock subject to this grant on November 7, 2013, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of November 7, 2013 thereafter through November 7, 2016.
F2: These options shall become exercisable upon the fulfillment of certain performance criteria.
F3: These options shall become exercisable with respect to 25% of the shares of common stock subject to this grant on May 23, 2014, the first anniversary of the date of grant, and with respect to an additional 12.5% of the shares of common stock subject to this grant on each sixth month anniversary of May 23, 2014 thereafter through May 23, 2017.